This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Thursday's Small-Cap Winners & Losers

Accelr8 Technology (AXK) and Fonar (FONR - Get Report), a couple of health-care stocks, were among the small-cap winners Thursday.

Accelr8 shares rocketed 48% after the Denver-based company received a notice of allowance on a patent covering methods used in its BACcel rapid diagnostic platform, which quickly identifies major multiple drug resistant bacteria, or "superbugs." That means the patent -- Accelr8's first for that system -- is close to being issued. Shares were up $1.18 to $3.64.

Fonar, a medical-equipment maker based in Melville, N.Y., soared 24.5% to $7.32 after Health Diagnostics ordered six of its Fonar Upright Multi-Position magnetic resonance imaging (MRI) machines. Terms weren't disclosed.

Elsewhere, WSI Industries (WSCI - Get Report) upped the fiscal 2008 sales forecast for its developing-energy business to between $10 million and $11 million from the prior range of $6 million to $8 million. Shares of the Monticello, Minn., company vaulted $1.58, or 30.6%, to $6.75.

And Sharper Image (SHRP) board Chairman Jerry Levin upped his holdings in the company by two-thirds to 250,000 shares as CEO Steven Lightman picked up about another 89,000 shares for a total of some 239,000. Three VPs and another board member also recently bought up Sharper Image stock, as disclosed in regulatory filings last night.

The San Francisco specialty retailer flew 45.5% higher at $2.72, recovering from some of last week's losses after a court rejected a class-action lawsuit settlement regarding one of its products.
1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
CGX $64.84 -0.78%
FONR $15.30 0.00%
NKTR $15.64 0.00%
PFE $32.87 0.00%
WSCI $4.20 0.00%


Chart of I:DJI
DOW 17,813.39 +1.20 0.01%
S&P 500 2,088.87 -0.27 -0.01%
NASDAQ 5,116.1430 +13.3350 0.26%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs